NCT06730347: A Study of Lorigerlimab in Participants With Advanced Solid Tumors
- State
- Under way
- Phase
- Phase 2
- People
- 80 planned
- Started
- 1 May 2025
- Primary completion
- Jul 2027
- Arms
- Cohort A (PROC) high dose, Cohort A (PROC) low dose, Cohort B (CCGC), Cohort C (CCGC)
- Results
- None posted
- 12 Dec 2024: Trial registered
- 1 May 2025: Trial started